The differences between the proportion of NAFLD among FSH quartiles was not significant (P = 0.067), but the prevalence of NAFLD in Q4 was significantly higher than that in Q1 (P = 0.048). Here, BRD2 is linked to metabolic dysfunction-associated steatotic liver disease.